SCHEMBL25413085

SCHEMBL25413085

Cc1ncsc1-c1ccc([C@H](CO)NC(=O)[C@@H]2CC(O)CN2C(=O)[C@@H](N=[N+]=[N-])C(C)C)cc1

nearest known ligand 0.61

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
VHL P40337 20/20 0.61
ELOC Q15369 4/20 0.51
ELOB Q15370 4/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25411369 1.00 VHL (0.61) VHLELOCELOB
SCHEMBL25411363 1.00 VHL (0.61) VHLELOCELOB
SCHEMBL25413091 1.00 VHL (0.61) VHLELOCELOB
SCHEMBL31297445 0.92 VHL (0.59) VHLELOCELOB
SCHEMBL30843443 0.91 VHL (0.67) VHLELOCELOB
SCHEMBL31398422 0.91 VHL (0.67) VHLELOCELOB
SCHEMBL30760040 0.87 VHL (0.46) VHLELOCELOB
SCHEMBL30760018 0.86 VHL (0.46) VHLELOCELOB
SCHEMBL30760137 0.86 VHL (0.46) VHLELOCELOB
SCHEMBL30760102 0.86 VHL (0.44) VHLELOCELOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024034123-A1 PHARMACEUTICAL COMPOSITION CONTAINING HETEROCYCLIC COMPOUND アステラス製薬株式会社 2024-02-15 WO disclosed
WO-2024034657-A1 PHARMACEUTICAL COMPOSITION COMPRISING HETEROCYCLIC COMPOUND アステラス製薬株式会社 2024-02-15 WO disclosed
WO-2023171781-A1 HETEROCYCLIC COMPOUND FOR INDUCING DEGRADATION OF G12D MUTANT KRAS PROTEIN アステラス製薬株式会社 2023-09-14 WO disclosed
WO-2022173032-A1 QUINAZOLINE COMPOUND FOR INDUCING DEGRADATION OF G12D-MUTATION KRAS PROTEIN アステラス製薬株式会社 2022-08-18 WO disclosed